These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 196433)

  • 21. [Factitious hypoglycaemia in an insulin-dependent diabetic: the value of the estimation of immunoreactive C peptide and insulin blood levels (author's transl)].
    Boyer J; Rohmer V; Davert A; Joubaud F
    Nouv Presse Med; 1979 Jul 14-28; 8(32):2627. PubMed ID: 493062
    [No Abstract]   [Full Text] [Related]  

  • 22. [Replacement of insulin by fasting C-peptide in modified homeostasis model assessment to evaluate insulin resistance and islet beta cell function].
    Li X; Zhou ZG; Qi HY; Chen XY; Huang G
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Aug; 29(4):419-23. PubMed ID: 16134594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation between the routine 6-min. C-peptide value and the AUC after I.V. glucagon injection in NIDDM patients.
    Kølendorf K; Thorsteinsson B; Billesbølle P; Poulsen S
    Horm Metab Res; 1982 Dec; 14(12):675-6. PubMed ID: 7152483
    [No Abstract]   [Full Text] [Related]  

  • 24. [C peptide and pro-insulin].
    Kuzuya H
    Nihon Rinsho; 1977 Feb; 35(2):235-41. PubMed ID: 323542
    [No Abstract]   [Full Text] [Related]  

  • 25. Home blood glucose levels, glycosylated haemoglobin and serum C-peptide levels in diabetics receiving different insulin regimens.
    Paisey RB; Bradshaw P; Burke BJ; Macfarlane DG; Hartog M
    J R Coll Physicians Lond; 1982 Apr; 16(2):108-12. PubMed ID: 7042962
    [No Abstract]   [Full Text] [Related]  

  • 26. [Dynamics of the glucagon and C-peptide content in Itsenko-Cushing disease].
    Arapova SD; Zavadskiĭ PS; Marova EI
    Sov Med; 1980; (2):42-7. PubMed ID: 6987746
    [No Abstract]   [Full Text] [Related]  

  • 27. [Plasma C-peptide concentration in normal and different types of diabetic subjects (author's transl)].
    Lu ZL
    Zhonghua Nei Ke Za Zhi; 1981 Aug; 20(8):471-4. PubMed ID: 7039990
    [No Abstract]   [Full Text] [Related]  

  • 28. Exogenous insulin needs. Relationship with duration of diabetes, C-peptidemia, insulin antibodies, and retinopathy.
    Haumont D; Dorchy H; Toussaint D; Despontin M
    Helv Paediatr Acta; 1982 May; 37(2):143-50. PubMed ID: 7047466
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of metformin on blood glucose, insulin and C-peptide responses to glucagon in non-insulin dependent diabetics.
    Ferlito S; Del Campo F; Di Vincenzo S; Damante G; Coco R; Branca S; Fichera C
    Farmaco Sci; 1983 Apr; 38(4):248-54. PubMed ID: 6345193
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Diagnosis of islet cell adenoma].
    Bottermann P
    Med Klin; 1979 Dec; 74(51-52):1943-51. PubMed ID: 232238
    [No Abstract]   [Full Text] [Related]  

  • 31. [Blood CPR levels in diabetes mellitus during insulin therapy, with special reference to the characteristics of PLC (proinsulin-like components) and C-peptide in fractional analysis].
    Oyama H; Nakajima Y; Amagu A; Matsumura S; Nishida S
    Horumon To Rinsho; 1977 Oct; 25(10):1107-12. PubMed ID: 589809
    [No Abstract]   [Full Text] [Related]  

  • 32. [Blood serum levels of C-peptide and insulin in diabetics and healthy persons after intravenous administration of glucagon and glucose].
    Jayyab AK; Heding LG; Czyzyk A; Malczewski B; Krókewski AS
    Pol Arch Med Wewn; 1980 Sep; 64(3):229-38. PubMed ID: 7003563
    [No Abstract]   [Full Text] [Related]  

  • 33. Plasma proinsulin, C-peptide and insulin in diagnostic suppression tests for insulinomas.
    Turner RC; Heding LG
    Diabetologia; 1977 Dec; 13(6):571-7. PubMed ID: 201531
    [No Abstract]   [Full Text] [Related]  

  • 34. Plasma insulin, C-peptide and glucagon concentrations in patients with insulin-independent diabetes treated with chlorpropamide.
    Frier BM; Ashby JP; Nairn IM; Baird JD
    Diabete Metab; 1981 Mar; 7(1):45-9. PubMed ID: 7016620
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determination of free and total insulin and C-peptide in insulin-treated diabetics.
    Kuzuya H; Blix PM; Horwitz DL; Steiner DF; Rubenstein AH
    Diabetes; 1977 Jan; 26(1):22-9. PubMed ID: 830562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Changes in CPR and blood metabolites during glucose loading in healthy subjects and patients with various diseases].
    Sakamoto N; Hotta G
    Horumon To Rinsho; 1977 Oct; 25(10):1081-9. PubMed ID: 589807
    [No Abstract]   [Full Text] [Related]  

  • 37. Insulin therapy in relation to circulating C-peptide levels.
    Beischer W; Kerner W; Raptis S; Keller L; Beischer B; Pfeiffer EF
    Diabetes; 1978; 27 Suppl 1():235-40. PubMed ID: 415925
    [No Abstract]   [Full Text] [Related]  

  • 38. [Radioimmunoassay of serum C-peptide immunoreactivity by C-peptide test "Shionogi" (author's transl)].
    Ban Y; Kojima T; Inoue Y; Kimura H; Awaya Y
    Horumon To Rinsho; 1981 Aug; 29(8):991-9. PubMed ID: 7318223
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical role of the determination of immunoreactive insulin and C-peptide in children with diabetes mellitus].
    Kravets EB
    Pediatriia; 1983 Mar; (3):42-4. PubMed ID: 6346250
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical evaluation of C peptide kit "Shionogi (6951-s)" with special reference to the patients of diabetes mellitus (author's transl)].
    Odagiri R; Hirata Y; Akashi H; Sasaki M; Demura H
    Horumon To Rinsho; 1981 Mar; 29(3):355-63. PubMed ID: 7273444
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.